Physician profile
Gerald E Beckham
NPI 1750440491
$3,386.51
in general payments reported to CMS, 2019-2025
21 companies · $654 in 2025
The $654 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $380 · 2021: $348 · 2022: $633 · 2023: $500 · 2024: $459 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $449.06 | 2019-2025 | Aveir, Perclose Prostyle, Xience Skypoint |
| Cardiovascular Systems INC. | $423.37 | 2019-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $358.85 | 2023-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Opticross |
| Teleflex LLC | $347.04 | 2019-2023 | Guideliner |
| Medtronic, INC. | $290.24 | 2021-2025 | Pulseselect, Cobalt Dr Mri Surescan, Affera Mapping System |
| Abiomed | $284.60 | 2020-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.48 | 2023-2025 | Lifevest |
| Shockwave Medical, INC | $186.31 | 2021-2022 | |
| Medtronic USA, INC. | $167.15 | 2019 | |
| Kestra Medical Technology Services, INC. | $143.10 | 2024-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $138.86 | 2019-2020 | |
| Biotronik INC. | $88.30 | 2022-2025 | Biomonitor, Orsiro Mission |
| Chiesi USA, INC. | $70.97 | 2020-2022 | |
| Philips North America LLC | $45.03 | 2021 | |
| Neurocrine Biosciences, INC. | $30.95 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $30.06 | 2025 | |
| Heartflow, INC. | $28.96 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals, Ltd. | $24.77 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.53 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $18.92 | 2025 | |
| Astellas Pharma US INC | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Beckham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.